Prostate cancer does not show particularly high glucose uptake, and this has prompted the development of dedicated tracers, i.e., prostate-specific membrane antigen (PSMA) ligands, which are typically labeled with gallium-68 in current practice. The gene discussed is FOLH1; the disease is Familial prostate cancer.